🧠💙 May is Huntington's Disease Awareness Month
May 7, 2025
At Pharmidex, we stand in solidarity with individuals and families affected by Huntington’s Disease a rare, inherited neurodegenerative condition that impacts the mind, body, and spirit.
Throughout May, we reaffirm our commitment to advancing neuroscience research and supporting drug discovery efforts aimed at neurodegenerative diseases.
Our team is proud to collaborate with partners working toward meaningful therapies that can improve quality of life and bring hope to the HD community.
Let’s raise awareness. Let’s drive innovation. Let’s stand together.
#HuntingtonsDisease #HDAwarenessMonth #Neuroscience #DrugDiscovery #Pharmidex #RareDiseases #PatientFirst
This initiative provides a fantastic opportunity to learn directly from key voices across the MSCA community, including insights from a project coordinator, beneficiary, and third-country partner, all sharing valuable lessons and best practices. We are proud to announce that our Managing Director, Professor Mo Alavijeh ( Pharmidex , University of Hertfordshire ), will participate in the Round Table Discussion on “MSCA Staff Exchanges: Challenges and Opportunities”, including an interactive Q&A session. Mo will be attending in person at the Universitat d'Alacan t and is looking forward to engaging with attendees, building new connections, and exploring collaborative opportunities, particularly with those interested in working alongside a UK-based SME deeply committed to international research excellence. Monika Holik , Begoña Arano , Sotirios Kiokias , Rodrigo Gutierrez Dominguez , Xavier Eekhout Chicharro , Joaquin Silvestre , Izaskun Lacunza , Julio Marchamalo Amado , Mónika Holik
We’re excited to announce that Pharmidex will be exhibiting at the BMCS 5th Synthesis in Drug Discovery and Development Conference, taking place from Tuesday 3rd to Wednesday 4th June 2025 🔗 https://lnkd.in/e_GJM8S7 Our Business Development Manager, J anette Dalay Robertson , will be attending and is looking forward to engaging with fellow professionals to foster collaborations and explore how Pharmidex can support your drug discovery and development journey. Whether you're looking for expertise in in silico, ADME, DMPK, bioanalysis, or neuroscience models, stop by our booth and let’s connect! 💬 Don’t miss the chance to meet Janette Dalay Robertson and discover how Pharmidex promotes scientific excellence through flexible, high-quality preclinical research partnerships.
At Pharmidex , we stand in solidarity with all patients, families, and healthcare professionals impacted by blood cancers. This day is a powerful reminder of the urgent need for continued innovation, collaboration, and compassion in the fight against these life-threatening diseases. Through our cutting-edge preclinical services, including: PK/ADME studies CNS penetration & efficacy models in vivo/in vitro pharmacology bioanalytical and regulatory support  we contribute to the development of safer, more effective therapies for blood cancers. 🧬 We’re proud to collaborate with leading biopharma companies, academic institutions, and charities to accelerate the discovery and delivery of new treatments. ❤️ Today, we renew our commitment to this mission working towards a future where every patient has access to a cure. 🔗 Learn more and support the cause: https://www.dkms.org.uk
